Imipramine-Flupenthixol Decanoate Interaction Journal Articles

abstract

• The authors describe a case in which flupenthixol decanoate and imipramine were co-administered to a patient with schizophrenia, resulting in extremely high levels of imipramine and its metabolite, desipramine. The literature on the co-administration of neuroleptics and antidepressants is reviewed and guidelines for limiting possible iatrogenic effects of the combination are suggested.

authors

• Cook, Peter
• Dermer, Stanley W
• Cardamone, Joey

status

• published 

publication date

• April 1986

has subject area

• 11 Medical and Health Sciences (FoR)
• 17 Psychology and Cognitive Sciences (FoR)
• Adult (MeSH)
• Antidepressive Agents, Tricyclic (MeSH)
• Antipsychotic Agents (MeSH)
• Desipramine (MeSH)
• Drug Interactions (MeSH)
• Flupenthixol (MeSH)
• Humans (MeSH)
• Imipramine (MeSH)
• Male (MeSH)
• Psychiatry (Science Metrix)
• Schizophrenia, Paranoid (MeSH)
• Thioxanthenes (MeSH)
• Trazodone (MeSH)

published in

• Canadian Journal of Psychiatry  Journal

keywords

• Adult
• Antidepressive Agents, Tricyclic
• Antipsychotic Agents
• Desipramine
• Drug Interactions
• Flupenthixol
• Humans
• Imipramine
• Male
• Schizophrenia, Paranoid
• Thioxanthenes
• Trazodone

Digital Object Identifier (DOI)

• 10.1177/070674378603100310

PubMed ID

• 2871918

start page

• 235

end page

• 237

volume

• 31

issue

• 3